Moderna, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MRNA | 261780.KQ | 0A3M.IL | VIR | NVAX | LGND | |
|---|---|---|---|---|---|---|
| Market cap | 103.15B | 103.62B | 25.17B | 1.99B | 1.76B | 6.32B |
| P/E (TTM) | — | — | 5.1 | — | — | 127.0 |
| Forward P/E | -56.4 | — | 5.1 | -4.8 | -65.0 | 25.9 |
| Price/book | 15.2 | — | 1.1 | 2.1 | -9.2 | 6.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +961.98% | +44.97% | −13.17% | +129.88% | +40.32% | +51.82% |
| Today | +13.11% | −2.90% | +2.81% | +4.90% | +10.02% | +0.83% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All MRNA news ›Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting
Initial Phase 1/2 data highlight the potential of Moderna's multiplexed mRNA approach in relapsed or refractory multiple myeloma The Company expects to present updated clinical data from the ongoing Phase 1/2 MyEngage trial at the ASH…
Universal Health Services, Tenet Healthcare, Moderna, Novavax, and Intuitive Surgical stocks trade up, what you need to know
StockStory A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senate, easing regulatory u
ELEVA – Moderna 2020, GDA Join Forces To Streamline Italian Retail Logistics
Headquartered in Salerno with €1 million in share capital, the 50/50 joint venture brings together a combined network of 409 stores across the regions of Campania, Calabria, Basilicata, Puglia, Lazio, Abruzzo and Molise. Together, the two…
Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa
Moderna Ebola vaccine picked for Phase 2/3 trial (MRNA:NASDAQ) Seeking Alpha - Moderna (MRNA) announced on Wednesday that an expert panel of the World Health Organization has recommended using its Ebola vaccine mRNA-1469 in a Phase 2/3…
CK Life Sciences forms new subsidiary to advance its therapeutic cancer vaccine
CK Life Sciences (0775) said it has established a new subsidiary called Sequencio Therapeutics Company to advance its therapeutic cancer vaccine portfolio. CK Life Sciences forms new subsidiary to advance its therapeutic cancer vaccine CK…
CK Life Sciences jumps 9pc ahead of cancer vaccine data reveal
Shares of CK Life Sciences (0775) briefly jumped 9 percent on Wednesday after Sequencio Therapeutics, its subsidiary, announced plans to present new data from its lead cancer vaccine programmes. Sequencio Therapeutics will unveil new data…
Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study
Corsicana Daily Sun WHO Technical Advisory Group recommends mRNA-1469 for inclusion in efficacy study following encouraging Phase 1 clinical results CAMBRIDGE, MA / ACCESS Newswire / November 4, 2026 / Moderna, In
Ebola: WHO clears Oxford, Moderna vaccines for trials
The World Health Organization has approved two experimental vaccines for clinical trials targeting the Bundibugyo strain of the Ebola virus. The approval comes as the current outbreak across Africa has claimed over 5,300 lives, with the…
Moderna's Cancer Vaccine Is Incredibly Promising, but This Could Be a Major Obstacle to Its Success
Moderna and Merck have developed a cancer vaccine that has been highly effective in treating melanoma patients. In a late-stage trial, it reduced the risk of death and melanoma recurrence by 42% when paired with Keytruda. The problem is…
Could Investing in Moderna's Stock Double Your Money?
The healthcare stock has generated massive returns this year and may still have room to rise even higher in the future. Moderna (MRNA +3.45%) has generated terrific gains for investors this year, as the stock has skyrocketed more than 650%…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com36
- seekingalpha.com24
- 247wallst.com23
- theglobeandmail.com22
- fool.com18
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.